Telehealth is a tool, not a trial design. Learn how televisits, ePRO, and remote monitoring fit into traditional, hybrid, and decentralized clinical trials.
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
- How Can AI Change Computerized System Validation?
- Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Enabling Regulatory Support For eSource
Delve into an illustration of how robust EDC systems fully support the operational requirements introduced by the decision to leverage eSource data.
-
How Capturing Data Directly Is Transforming Trials
With the right eSource technology, discover how trial data can be aggregated, integrated, and classified to accelerate data analysis for insight-based decisions in real time.
-
Minimizing Hurdles For Patients During The eConsent Process
Learn how eConsent digitalizes the trial participant consent process through increasingly simplified models designed to improve comprehension and boost engagement.
-
5 Key Takeaways From The FDA's Real-World Evidence Guidance
With our advanced technology and expertise, sponsors can confidently conduct RWE studies that are efficient and aligned with the FDA’s data-driven vision for healthcare.
-
One Day, Clinical Trials Will Represent The Real World
What needs to happen for RWE to reach its full regulatory potential? We discussed this with industry leaders during the One Day Summit, and here are some key takeaways.
-
Addressing The Specific Complexities Of Oncology eCOA Clinical Trials
What are the specific tools and keys to conduct eCOA trials in oncology successfully? This article identifies some of the relevant solutions to tackle oncology protocol complexities.
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
Evidence Generation Evolved
Explore how innovative strategies are cutting clinical trial times in half and accelerating the delivery of life-saving treatments.
-
The New Standard In Participant-Centric Trials
Clinical technology must serve both scientific rigor and human experience—and Castor is positioning itself at the forefront of this participant-led future.
-
8 Key Applications Of Real-World Data In Multiple Myeloma Therapy Development
Explore how therapeutic area (TA) datasets can be leveraged to address the challenges multiple myeloma (MM) presents in the field of hematologic malignancies.
FROM THE EDITOR
- Telehealth In Clinical Trials: What You Need To Know
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
- RWE Is Growing Up, And Here's Why That Matters
FEATURED PRODUCTS & SERVICES
RECENT NEWSLETTERS
- 02.26.26 -- EU AI Act Compliance For eTMF Systems: What Clinical Tech Leaders Need To Know
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
- 01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders